The widespread adoption of GLP-1 weight-loss drugs is altering consumer behavior, particularly in apparel purchases. This trend is expected to generate up to $13 billion in new spending, creating opportunities for certain clothing companies.
GLP-1 Drugs Drive Shift in Consumer Spending, Benefiting Apparel Retailers
HealthcareConsumer SpendingRetailPharmaceuticalsGLP-1



